Amarantus Bioscience Holdings Inc (AMBS)

[dh4systems]

How about direct funding coming from Sanford-Burnham. I posted yesterday about Sanford-Burnham.

...
Another unique aspect of Sanford-Burnham’s approach is its increased emphasis on diversified funding sources, including reinvested drug discovery revenue, philanthropy, and grants. In support of its long-term strategic vision, the Institute also announced that it has received a $275 million pledge payable over 10 years, the largest philanthropic commitment ever received by the Institute. This gift, which was given anonymously, will propel the Institute toward achieving its goal of raising $500 million over the next decade. ...

“http://www.newswise.com/articles/sanford-burnham-board-of-trustees-approves-new-10-year-strategic-vision?ret=/articles/list&category=business&page=1&search%5Bstatus%5D=3&search%5Bsort%5D=date+desc&search%5Bsection%5D=40&search%5Bhas_multimedia%5D=

CEO Henry Nordhoff, San Diego biotech veteran and executive chairman of Banyan Biomarkers is on the board of Stanford-Burnham


“There’s an awful lot of intellectual capital in San Diego, with the Burnham (Sanford-Burnham Medical Research Institute), I sit on that board[color=red][/color] and that of the Preuss School, coming up with innovations in education. But there’s an informality and unpretentiousness about San Diego. People will welcome you to these various boards, and you can have an impact almost immediately. And the climate is not bad, but basically it’s the people.”


http://www.utsandiego.com/news/2013/feb/04/san-diego-biotech-advantage-outweighs/

Sanford Burnham Medical Research Institute

http://www.sanfordburnham.org/Pages/Splash.aspx